← Leaderboards
Scott M. Grundy
University Of Texas Sw Med Ctr/Dallas
$3,966,518
Attributed
$3,966,518
Total exposure
12
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $115.4K · FY2005–07$200K$150K$100K$50K$0
'05
'06
'07
Funding mix
By agency
NIH$3,966,518 · 12
By mechanism
M01$3,516,518 · 11
K07$450,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Sw Med Ctr/Dallas
Same institution · by research overlap
- Joseph L Goldstein$29,369,162
- Ishwarlal Jialal$7,903,141
- Andrew R. Zinn$19,641,031
- Joyce J Repa$3,001,471
- Charles Y.c Pak$11,557,463
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectNutrition Related TagBlood Lipoprotein MetabolismHuman Therapy EvaluationLow Density LipoproteinHigh Density LipoproteinsCholesterolObesityAdipose TissueInsulin Sensitivity /ResistanceBlood Disorder ChemotherapyAndrogensCaucasian AmericanAtherosclerosisAfrican AmericanCardiovascular Disorder PreventionCurriculumCardiovascular Disorder ChemotherapyAntihyperlipoproteinemic AgentDietary LipidDiet TherapyDisease /Disorder Proneness /RiskDosage
Grant awards (25)
EZETIMIBE OR STATIN MONOTHERAPY VS CO-ADMINISTRATION IN ETHNIC GROUPS$34,271
M01 · FY2007 · RR · contact PI
EZETIMIBE OR STATIN MONOTHERAPY VS CO-ADMINISTRATION IN ETHNIC GROUPS$92,397
M01 · FY2006 · RR · contact PI
COMPARISON OF TRIGLYCERIDES ON PLASMA LEVELS OF BETAHYDROXYBUTERANE$16,236
M01 · FY2006 · RR · contact PI
EFFECT OF N-3 FATTY ACIDS ON LIVER FAT CONTENT$6,790
M01 · FY2006 · RR · contact PI
EFFECT OF N-3 FATTY ACIDS ON LIVER FAT CONTENT$54,852
M01 · FY2005 · RR
EZETIMIBE OR STATIN MONOTHERAPY VS CO-ADMINISTRATION IN ETHNIC GROUPS$12,740
M01 · FY2005 · RR
Effect of n-3 fatty acids on liver fat content$85,492
M01 · FY2004 · RR
GLUCOSE METABOLISM IN OBESE/NONOBESE NONINSULIN DEPENDENT DIABETES PATIENTS$321,374
M01 · FY2002 · RR
GENETIC POLYMORPHISMS OF HEPATIC LIPASE$321,374
M01 · FY2002 · RR
EFFECT OF LIFIBROL ON PLASMA LIPOPROTEINS$321,374
M01 · FY2002 · RR
METABOLIC BASIS OF RACIAL DIFFERENCES IN HDL LEVELS$321,374
M01 · FY2002 · RR
CAUSES AND MANAGEMENT OF PRIMARY HYPERCHOLESTEROLEMIA$321,374
M01 · FY2002 · RR
CARDIOVASCULAR NUTRITION IN MEDICAL EDUCATION$150,000
K07 · FY2002 · HL
GENETIC POLYMORPHISMS OF HEPATIC LIPASE$321,374
M01 · FY2001 · RR
EFFECT OF LIFIBROL ON PLASMA LIPOPROTEINS$321,374
M01 · FY2001 · RR
METABOLIC BASIS OF RACIAL DIFFERENCES IN HDL LEVELS$321,374
M01 · FY2001 · RR
GLUCOSE METABOLISM IN OBESE/NONOBESE NONINSULIN DEPENDENT DIABETES PATIENTS$321,374
M01 · FY2001 · RR
CAUSES AND MANAGEMENT OF PRIMARY HYPERCHOLESTEROLEMIA$321,374
M01 · FY2001 · RR
CARDIOVASCULAR NUTRITION IN MEDICAL EDUCATION$150,000
K07 · FY2001 · HL
CARDIOVASCULAR NUTRITION IN MEDICAL EDUCATION$150,000
K07 · FY2000 · HL
GENETIC POLYMORPHISMS OF HEPATIC LIPASE$0
M01 · FY2000 · RR
EFFECT OF LIFIBROL ON PLASMA LIPOPROTEINS$0
M01 · FY2000 · RR
METABOLIC BASIS OF RACIAL DIFFERENCES IN HDL LEVELS$0
M01 · FY2000 · RR
GLUCOSE METABOLISM IN OBESE/NONOBESE NIDDM PTS$0
M01 · FY2000 · RR
CAUSES AND MANAGEMENT OF PRIMARY HYPERCHOLESTEROLEMIA$0
M01 · FY2000 · RR